Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Roblox Corp — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.44 (market cap $5.07B), while Roblox Corp trades at $35.61 (market cap $25.87B). The key difference: Roblox Corp is far larger — about 5.1× ACADIA Pharmaceuticals Inc.'s market cap, and ACADIA Pharmaceuticals Inc. is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals.
| ACAD | RBLX | |
|---|---|---|
Market Cap | $5.07B | $25.87B |
Sector | Health | Media |
52-Week High | $29.41 | $141.56 |
52-Week Low | $20.06 | $35.60 |
Enterprise Value | $4.19B | $24.70B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACADIA Pharmaceuticals (ACAD) trades at $29.39, up 0.62% on the day, with strong earnings momentum after Q2 2026 results beat expectations. The stock shows bullish technical signals from moving averages, though oscillators suggest potential overbought conditions. Revenue growth has been robust, rising from $517M in 2022 to $1.07B in 2025, with net income turning positive and margins expanding significantly. Recent news highlights FDA Fast Track designation for remlifanserin and raised 2026 revenue guidance.
Outlook remains positive driven by product sales growth and pipeline advancements, but risks include clinical trial outcomes and competitive pressures. Analyst consensus is strongly bullish with a $33.89 price target, indicating ~15% upside. Investment appeal hinges on execution of commercial strategy and successful drug development.
Roblox (RBLX) trades at $37.05, down 1.96% amid a bearish technical signal and negative net income. Revenue growth remains strong, reaching $4.89B in 2025, but profitability is elusive with a -17.61% net margin. The stock faces headwinds from multiple class-action lawsuits announced in early August 2026, creating significant legal overhangs. Analyst consensus is mixed with a $45.67 price target, suggesting potential upside if operational improvements materialize.
The outlook hinges on Roblox's ability to translate robust user engagement into sustained profitability. Near-term risks from litigation and high valuation multiples (P/S 4.51, P/B 170.23) pressure the stock, but consistent revenue growth and a bullish oscillator signal offer a contrarian opportunity for long-term investors willing to tolerate volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
